
The electrosurgical devices global market is segmented mainly based on products, application, end-user and geography. The electrosurgical device's product market is segmented into electrosurgical electrodes, instruments/units, smoke management, and accessories. Instruments/units market accounted for the largest share of XX% in 2020, generating revenue of $XX million and expected to reach $XX million by 2027 by growing with a high single digit CAGR of XX% from 2020 to 2027. Electrosurgical instruments/units are further sub-segmented as monopolar and bipolar instruments, where bipolar instruments occupied the largest share of XX% in 2020 and projected to grow at a high single digit CAGR of XX% from 2020 to 2027. The monopolar instruments market is further segmented into contact and non-contact monopolar instruments. Contact monopolar devices generated revenue of $XX million in 2020 and are expected to reach $XX million by 2027 growing at a mid single digit CAGR of XX% from 2020 to 2027. The non-contact monopolar devices market is expected to grow at a high single digit CAGR of XX% from 2020 to 2027. The contact monopolar instruments are further segmented into electrosurgical electrodes, electrosurgical pencils, suction coagulators & irrigation devices and others. Among the contact monopolar instrument segments, electrosurgical pencils commanded the largest revenue of $XX million in 2020 and are expected to grow at a mid single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027. The non-contact monopolar instruments are further segmented into, argon based systems and helium based systems, among these, Argon based systems segment commanded the largest revenue of share XX% in 2020 and is expected to grow at a high single digit CAGR of XX% from 2020 to 2027.
The bipolar instruments market is further sub-segmented into vessel sealing devices and bipolar forceps. The vessel sealing devices commanded the largest revenue of $XX million in 2020 and is expected to grow at a high single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027. The electrosurgical accessories market is segmented into patient return electrodes, smoke management accessories, footswitches, cord, cables and adapters and others. Among these, the patient return electrodes segment commanded the largest revenue of $XX million in 2020 and is expected to grow at a mid single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027.
Based on application the market is segmented into cardiovascular, cosmetic & dermatology, dental, gastrointestinal, general surgery, gynecology, neurology, oncology, orthopedic, urology and others (ENT & Ophthalmology). In the application market, oncology commanded the largest revenue of $XX million in 2020 and is expected to grow at a double digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027. As more and more cancer patients opt for minimally invasive surgeries and robotic surgeries for treatment, the market is experiencing growth.
Based on the end-user the market is segmented into hospitals, ambulatory surgical centers and clinics. Among these, the hospital segment accounted for the largest revenue of $XX million in 2020 and is expected to grow at a mid single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027. Ambulatory surgical centers segment is expected to grow at a high single digit CAGR of XX% from 2020 to 2027.
Based on geography the market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K. and rest of E.U.), Asia-Pacific (Japan, China, India and rest of APAC), and the Rest of the World (Brazil, Middle East & Africa and Rest of Latin America). North-America commanded the largest revenue of $XX million in 2020 and the market is expected to grow at a CAGR of XX% from 2020 to 2027 due to advancements in technology, adoption of electrosurgical instruments in all types of surgeries, minimally- invasive surgeries, healthcare expenditures by government reforms, and an aging population and availability of skilled labors. Asia-Pacific is expected to grow at a strong CAGR of XX% from 2020 to 2027 due to growing awareness of the people and increasing demand for safe, cost-effective minimally-invasive procedures.
Some of the major companies operating in the electrosurgical devices market area. B.Braun Melsungen AG (Germany), Apyx Medical Corporation (U.S.), Bowa Electronic GmbH & Co. KG (Germany), CONMED Corporation (U.S.), Medtronic, PLC (Ireland), Erbe Electromedizin GmbH (Germany), Johnson & Johnson (Ethicon) (U.S.), Olympus Corporation (Japan), Smith & Nephew PLC (U.K.), Utah Medical Products Inc. (U.S.), Applied Medical Resources Corporation (U.S.), Boston Scientific Corporation (U.S.), Karl Storz SE & Co. KG (Germany), Arthrex Inc., (U.S.), Cooper Companies, Inc., (U.S.), Stryker Corporation (U.S.), Richard Wolf GmbH (Germany) and KLS Martin Group (Germany).
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT SCOPE
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
ÌýÌý2.6.1 MARKET SIZE ESTIMATION
ÌýÌý2.6.2 MARKET CRACKDOWN AND DATA TRIANGULATION
ÌýÌý2.6.3 SECONDARY SOURCES
ÌýÌý2.6.4 PRIMARY SOURCES
ÌýÌý2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
ÌýÌý2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
ÌýÌý2.6.7 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.4 MARKET DYNAMICS
ÌýÌý3.4.1 DRIVERS AND OPPORTUNITIES
ÌýÌýÌýÌý3.4.1.1 Increasing adoption of minimally invasive surgeries
ÌýÌýÌýÌý3.4.1.2 Rapid growth in the aging population
ÌýÌýÌýÌý3.4.1.3 The growing number of cosmetic surgery procedures
ÌýÌýÌýÌý3.4.1.4 Prevalence of obesity and its related surgeries
ÌýÌýÌýÌý3.4.1.5 Advancement in technology
ÌýÌýÌýÌý3.4.1.6 Demand for electrosurgical procedures in the emerging regions
ÌýÌý3.4.2 RESTRAINTS AND THREATS
ÌýÌýÌýÌý3.4.2.1 Risk of side effects
ÌýÌýÌýÌý3.4.2.2 Increase in the number of product recalls
ÌýÌýÌýÌý3.4.2.3 Preference for non-invasive procedures
ÌýÌýÌýÌý3.4.2.4 Healthcare reforms especially government pressure to minimize healthcare costs
ÌýÌýÌýÌý3.4.2.5 Pricing pressure on device manufacturers
ÌýÌýÌýÌý3.4.2.6 Postponement and cancellation of surgeries due to COVID-19
3.5 REGULATORY AFFAIRS
ÌýÌý3.5.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
ÌýÌýÌýÌý3.5.1.1 ISO 9001: 2015 Quality Management System
ÌýÌýÌýÌý3.5.1.2 ISO 13485 Medical Devices
ÌýÌý3.5.2 THE U.S.
ÌýÌý3.5.3 EUROPE
ÌýÌý3.5.4 CHINA
ÌýÌý3.5.5 INDIA
ÌýÌý3.5.6 JAPAN
3.6 PORTER’S FIVE FORCE ANALYSIS
ÌýÌý3.6.1 THREAT OF NEW ENTRANTS
ÌýÌý3.6.2 THREAT OF SUBSTITUTES
ÌýÌý3.6.3 RIVALRY AMONG EXISTING COMPETITORS
ÌýÌý3.6.4 BARGAINING POWER OF SUPPLIERS
ÌýÌý3.6.5 BARGAINING POWER OF BUYERS
3.7 MARKET SHARE ANALYSIS
ÌýÌý3.7.1 ELECTROSURGICAL DEVICES GLOBAL MARKET
3.8 PATENT TRENDS
3.9 REIMBURSEMENT SCENARIO
3.10 TECHNOLOGIC ADVANCEMENTS
ÌýÌý3.10.1 RADIOFREQUENCY BALLON ABLATION
ÌýÌý3.10.2 ECLIPSIA+ 27.12MHZ ADVANCED THERMOCOAGULATION SYSTEM
3.11 SUPPLY CHAIN ANALYSIS
3.12 VOLUME OF ELECTROSURGERY ASSITED SURGICAL PROCEDURES
4 ELECTROSURGICAL DEVICES MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 ELECTROSURGICAL GENERATORS AND MONITORS
4.3 ELECTROSURGICAL INSTRUMENTS/UNITS
ÌýÌý4.3.1 MONOPOLAR INSTRUMENTS
ÌýÌýÌýÌý4.3.1.1 Contact Monopolar Instruments
ÌýÌýÌýÌýÌýÌý4.3.1.1.1 Electrosurgical Electrodes
ÌýÌýÌýÌýÌýÌý4.3.1.1.2 Electrosurgical Pencils
ÌýÌýÌýÌýÌýÌý4.3.1.1.3 Suction Coagulators and Irrigation Devices
ÌýÌýÌýÌýÌýÌý4.3.1.1.4 Others
ÌýÌýÌýÌý4.3.1.2 Non-contact (plasma) monopolar instruments
ÌýÌýÌýÌýÌýÌý4.3.1.2.1 Argon Based Systems
ÌýÌýÌýÌýÌýÌý4.3.1.2.2 Helium Based Systems
ÌýÌý4.3.2 BIPOLAR INSTRUMENTS/UNITS
ÌýÌýÌýÌý4.3.2.1 Vessel Sealing Devices
ÌýÌýÌýÌý4.3.2.2 Bipolar Forceps
4.4 SMOKE MANAGEMENT SYSTEMS
4.5 ELECTROSURGICAL ACCESSORIES
ÌýÌý4.5.1 PATIENT RETURN ELECTRODES
ÌýÌý4.5.2 SMOKE MANAGEMENT SYSTEM ACCESSORIES
ÌýÌý4.5.3 FOOT SWITCHES, CORDS, CABLES AND ADAPTERS
ÌýÌý4.5.4 OTHER ACCESSORIES (DISPOSABLES, CARE AND CLEANING AGENTS)
5 ELECTROSURGICAL DEVICES MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 CARDIOVASCULAR SURGERY
5.3 COSMETIC & DERMATOLOGY SURGERY
5.4 DENTAL SURGERY
5.5 GASTROINTESTINAL SURGERY
5.6 GENERAL SURGERY
5.7 GYNECOLOGICAL SURGERY
5.8 NEUROLOGICAL SURGERY
5.9 ONCOLOGY
5.10 ORTHOPEDIC SURGERY
5.11 UROLOGY
5.12 OTHER SURGERIES
6 ELECTROSURGICAL DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS (ASC)
6.4 CLINICS/PHYSICIAN’S OFFICE
7 REGIONAL MARKET ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
ÌýÌý7.2.1 THE UNITED STATES (U.S.)
ÌýÌý7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
ÌýÌý7.3.1 GERMANY
ÌýÌý7.3.2 FRANCE
ÌýÌý7.3.3 UNITED KINGDOM (U.K.)
ÌýÌý7.3.4 REST OF EUROPE
7.4 ASIA PACIFIC
ÌýÌý7.4.1 JAPAN
ÌýÌý7.4.2 CHINA
ÌýÌý7.4.3 INDIA
ÌýÌý7.4.4 REST OF APAC
7.5 REST OF THE WORLD (ROW)
ÌýÌý7.5.1 BRAZIL
ÌýÌý7.5.2 REST OF LATIN AMERICA (LATAM)
ÌýÌý7.5.3 MIDDLE EAST & AFRICA
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.2 APPROVALS
8.3 NEW PRODUCT LAUNCHES
8.4 ACQUISITIONS
9 MAJOR COMPANIES
9.1 APPLIED MEDICAL RESOURCE CORPORATION
ÌýÌý9.1.1 OVERVIEW
ÌýÌý9.1.2 FINANCIALS
ÌýÌý9.1.3 PRODUCT PORTFOLIO
ÌýÌý9.1.4 KEY DEVELOPMENTS
ÌýÌý9.1.5 BUSINESS STRATEGY
ÌýÌý9.1.6 SWOT ANALYSIS
9.2 B. BRAUN MELSUNGEN AG
ÌýÌý9.2.1 OVERVIEW
ÌýÌý9.2.2 FINANCIALS
ÌýÌý9.2.3 PRODUCT PORTFOLIO
ÌýÌý9.2.4 KEY DEVELOPMENTS
ÌýÌý9.2.5 BUSINESS STRATEGY
ÌýÌý9.2.6 SWOT ANALYSIS
9.3 CONMED CORPORATION
ÌýÌý9.3.1 OVERVIEW
ÌýÌý9.3.2 FINANCIALS
ÌýÌý9.3.3 PRODUCT PORTFOLIO
ÌýÌý9.3.4 KEY DEVELOPMENTS
ÌýÌý9.3.5 BUSINESS STRATEGY
ÌýÌý9.3.6 SWOT ANALYSIS
9.4 ERBE ELEKTROMEDIZIN GMBH
ÌýÌý9.4.1 OVERVIEW
ÌýÌý9.4.2 FINANCIALS
ÌýÌý9.4.3 PRODUCT PORTFOLIO
ÌýÌý9.4.4 KEY DEVELOPMENTS
ÌýÌý9.4.5 BUSINESS STRATEGY
ÌýÌý9.4.6 SWOT ANALYSIS
9.5 JOHNSON & JOHNSON (ETHICON & MEGADYNE)
ÌýÌý9.5.1 OVERVIEW
ÌýÌý9.5.2 FINANCIALS
ÌýÌý9.5.3 PRODUCT PORTFOLIO
ÌýÌý9.5.4 KEY DEVELOPMENTS
ÌýÌý9.5.5 BUSINESS STRATEGY
ÌýÌý9.5.6 SWOT ANALYSIS
9.6 KLS MARTIN GROUP
ÌýÌý9.6.1 OVERVIEW
ÌýÌý9.6.2 FINANCIALS
ÌýÌý9.6.3 PRODUCT PORTFOLIO
ÌýÌý9.6.4 KEY DEVELOPMENTS
ÌýÌý9.6.5 BUSINESS STRATEGY
ÌýÌý9.6.6 SWOT ANALYSIS
9.7 MEDTRONIC, PLC
ÌýÌý9.7.1 OVERVIEW
ÌýÌý9.7.2 FINANCIALS
ÌýÌý9.7.3 PRODUCT PORTFOLIO
ÌýÌý9.7.4 KEY DEVELOPMENTS
ÌýÌý9.7.5 BUSINESS STRATEGY
ÌýÌý9.7.6 SWOT ANALYSIS
9.8 OLYMPUS CORPORATION
ÌýÌý9.8.1 OVERVIEW
ÌýÌý9.8.2 FINANCIALS
ÌýÌý9.8.3 PRODUCT PORTFOLIO
ÌýÌý9.8.4 KEY DEVELOPMENTS
ÌýÌý9.8.5 BUSINESS STRATEGY
ÌýÌý9.8.6 SWOT ANALYSIS
9.9 SMITH & NEPHEW, PLC
ÌýÌý9.9.1 OVERVIEW
ÌýÌý9.9.2 FINANCIALS
ÌýÌý9.9.3 PRODUCT PORTFOLIO
ÌýÌý9.9.4 KEY DEVELOPMENTS
ÌýÌý9.9.5 BUSINESS STRATEGY
ÌýÌý9.9.6 SWOT ANALYSIS
9.10 STRYKER CORPORATION
ÌýÌý9.10.1 OVERVIEW
ÌýÌý9.10.2 FINANCIALS
ÌýÌý9.10.3 PRODUCT PORTFOLIO
ÌýÌý9.10.4 KEY DEVELOPMENTS
ÌýÌý9.10.5 BUSINESS STRATEGY
ÌýÌý9.10.6 SWOT ANALYSIS
Ìý
Ìý
*If Applicable.
